Tag: biosimilars
on Apr 4, 2026
How Generic Drugs Save Trillions: The Real Impact on Healthcare Costs
Discover how generic drugs and biosimilars saved the US healthcare system $3.4 trillion over a decade and why they are critical for keeping prescription costs manageable.
on Feb 4, 2026
Biosimilar Safety Monitoring: How Adverse Events Are Tracked and Managed
Biosimilars aren't like generics. They need special safety monitoring due to their complex structure. This article explains how adverse events are tracked, challenges in reporting, and how regulators are adapting. Real-world examples and future improvements in biosimilar safety surveillance.